SCHEMBL12633898

SCHEMBL12633898

COC(=O)c1c(CNS(=O)(=O)c2ccc(C)cc2)n(S(=O)(=O)c2ccccc2)c2ncc(Cl)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 6/20 0.40
▸ MAPT P10636 5/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ AGTR1 P30556 1/20 0.38
▸ PSEN1 P49768 2/20 0.37
▸ PSEN2 P49810 2/20 0.37
▸ APH1B Q8WW43 2/20 0.37
▸ NCSTN Q92542 2/20 0.37
▸ APH1A Q96BI3 2/20 0.37
▸ PSENEN Q9NZ42 2/20 0.37
▸ POLB P06746 1/20 0.37
▸ PLA2G2A P14555 1/20 0.36
▸ PTGES O14684 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12633458 0.90 PTGDR2 (0.40) PTGDR2MAPTCA12CYP1A2CYP3A4
SCHEMBL2033730 0.84 PTGDR2 (0.40) PTGDR2PSEN1PSEN2APH1BNCSTN
SCHEMBL2041118 0.81 PTGDR2 (0.47) PTGDR2MAPTCYP1A2CYP3A4PLA2G2A
SCHEMBL2040047 0.81 GLA (0.39) PTGDR2MAPTAGTR1PSEN1PSEN2
SCHEMBL13572665 0.73 PTGDR2 (0.38) PTGDR2MAPTAGTR1PSEN1PSEN2
SCHEMBL2041243 0.73 PTGDR2 (0.41) PTGDR2ALDH1A1LMNAHTT
SCHEMBL2035534 0.72 PTGDR2 (0.41) PTGDR2PLA2G2A
SCHEMBL2038633 0.71 GLA (0.39) PTGDR2MAPTCYP3A4AGTR1PSEN1
SCHEMBL1889325 0.70 PTGDR2 (0.47) PTGDR2MAPTCYP1A2CYP3A4HTT
SCHEMBL2043551 0.70 PTGDR2 (0.47) PTGDR2MAPTCYP1A2CYP3A4PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073263-A1 1, 7 - DIAZACARBAZOLES AND THEIR USE IN THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2011-06-23 — — WO disclosed
Send feedback